To evaluate bioequivalence and pharmacokinetic properties of two formulations of sofosbuvir and ledipasvir in healthy Egyptian volunteers

Trial Profile

To evaluate bioequivalence and pharmacokinetic properties of two formulations of sofosbuvir and ledipasvir in healthy Egyptian volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Feb 2018 New trial record
    • 07 Feb 2018 Results published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top